BilimoriaKY, BentremDJ, KoCY, StewartAK, WinchesterDP, TalamontiMS, SturgeonC. 2007. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg, 246:375–381discussion 381–384.
2.
RouxelA, HejblumG, BernierMO, BoëllePY, MénégauxF, MansourG, HoangC, AurengoA, LeenhardtL. 2004. Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab, 89:5362–5368.
3.
MazzaferriEL, JhiangSM. 1994. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 97:418–428.
4.
HayID, ThompsonGB, GrantCS, BergstralhEJ, DvorakCE, GormanCA, MaurerMS, McIverB, MullanBP, ObergAL, PowellCC, van HeerdenJA, GoellnerJR. 2002. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg, 26:879–885.
